INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 225 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q4 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $117,179,523 | -12.6% | 3,068,330 | -5.8% | 0.03% | -11.1% |
Q2 2023 | $134,007,545 | -39.0% | 3,258,146 | -14.8% | 0.04% | -42.9% |
Q1 2023 | $219,520,110 | +2.4% | 3,823,726 | 0.0% | 0.06% | -3.1% |
Q4 2022 | $214,396,317 | +62.2% | 3,823,726 | +22.5% | 0.06% | +51.2% |
Q3 2022 | $132,203,000 | -36.8% | 3,120,947 | -19.4% | 0.04% | -33.8% |
Q2 2022 | $209,108,000 | -52.3% | 3,869,770 | -43.2% | 0.06% | -39.8% |
Q1 2022 | $438,138,000 | -20.4% | 6,817,924 | -17.0% | 0.11% | -11.5% |
Q4 2021 | $550,614,000 | -2.5% | 8,219,133 | -0.4% | 0.12% | -7.6% |
Q3 2021 | $565,012,000 | +0.3% | 8,250,452 | -0.0% | 0.13% | +0.8% |
Q2 2021 | $563,149,000 | -1.0% | 8,252,429 | +0.3% | 0.13% | -5.8% |
Q1 2021 | $568,624,000 | +6.3% | 8,230,231 | -0.1% | 0.14% | 0.0% |
Q4 2020 | $534,765,000 | +26.4% | 8,237,281 | -8.1% | 0.14% | +9.4% |
Q3 2020 | $423,066,000 | -3.5% | 8,959,576 | -4.0% | 0.13% | -8.6% |
Q2 2020 | $438,435,000 | +7.2% | 9,330,446 | +1.9% | 0.14% | -13.1% |
Q1 2020 | $408,908,000 | -23.1% | 9,153,999 | +0.4% | 0.16% | +0.6% |
Q4 2019 | $531,569,000 | -2.3% | 9,120,953 | +0.7% | 0.16% | -10.7% |
Q3 2019 | $543,967,000 | +7.6% | 9,055,551 | +0.0% | 0.18% | +10.6% |
Q2 2019 | $505,731,000 | +1.0% | 9,055,166 | +0.8% | 0.16% | +1.3% |
Q1 2019 | $500,758,000 | +15.2% | 8,987,035 | -6.8% | 0.16% | +5.3% |
Q4 2018 | $434,788,000 | -35.2% | 9,640,543 | -5.4% | 0.15% | -22.6% |
Q3 2018 | $670,966,000 | +6.7% | 10,186,218 | +4.3% | 0.20% | +13.4% |
Q2 2018 | $628,828,000 | +18.2% | 9,762,894 | +1.6% | 0.17% | +13.9% |
Q1 2018 | $532,006,000 | +15.6% | 9,613,406 | +0.0% | 0.15% | +11.9% |
Q4 2017 | $460,084,000 | +50.5% | 9,613,126 | +58.7% | 0.14% | +46.7% |
Q3 2017 | $305,754,000 | +43.9% | 6,056,932 | +55.4% | 0.09% | +39.4% |
Q2 2017 | $212,441,000 | +323.1% | 3,897,288 | +227.0% | 0.07% | +312.5% |
Q1 2017 | $50,211,000 | -37.2% | 1,191,800 | +28.0% | 0.02% | -38.5% |
Q4 2016 | $79,905,000 | +5.9% | 931,400 | +1.9% | 0.03% | +4.0% |
Q3 2016 | $75,451,000 | +85.1% | 914,000 | +78.9% | 0.02% | +78.6% |
Q2 2016 | $40,759,000 | – | 510,887 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |